Permissible Provider Collaborations During Covid & Beyond - McDermott

On The Horizon: Permissible Provider Collaborations During Covid-19 and Beyond


As the healthcare industry continues to cope with the Coronavirus (COVID-19) and form strategic and short- and long-term plans, providers are faced with numerous decisions that have critical antitrust implications. Whether seeking to collaborate with competitors for pandemic response or exploring potential transactional opportunities, there are both traditional antitrust guidelines and COVID-specific developments applicable to these business decisions.

Please join our team of health antitrust lawyers as they explore navigating compliance concerns and strategic antitrust considerations that providers should address as they contemplate and pursue cooperative relationships.

This webinar will offer insights on guardrails of collaboration in light of the pandemic, including:

  • Planning for COVID-19 related allocation issues, such as patient transfers, supplies and staffing
  • Avoiding antitrust violations in labor markets, particularly related to employee recruiting and wage arrangements
  • Navigating distressed deal opportunities and the failing firm defense
  • Considerations for strategic deal opportunities such as minority investment joint ventures

We want to ensure we address the issues of most importance to our participants, and we encourage you to submit your questions for the panel in advance during registration.

Dig Deeper

Miami, FL / McDermott Event / March 6-7, 2024

HPE Miami 2024

New York, NY / McDermott Event / October 13, 2023

HPE NYC 2023

London, UK / McDermott Event / September 21, 2023

HPE Europe 2023

San Francisco, CA / McDermott Event / June 27, 2023

AHLA Annual Meeting Reception 2023

San Francisco, CA / AHLA / June 26 - 28, 2023

AHLA Annual Meeting 2023

San Diego, CA / AIMed / June 4 - 7, 2023

AIMed Global Summit 2023

Get In Touch